ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $384,528 | +89533.6% | 15,050 | +0.7% | 0.08% | -9.6% |
| Q2 2023 | $429 | +11.7% | 14,950 | 0.0% | 0.09% | +16.0% |
| Q1 2023 | $384 | +42.8% | 14,950 | -5.7% | 0.08% | +32.8% |
| Q4 2022 | $269 | -99.9% | 15,850 | +1.3% | 0.06% | 0.0% |
| Q3 2022 | $261,000 | +11.1% | 15,650 | +4.7% | 0.06% | +15.1% |
| Q2 2022 | $235,000 | -38.0% | 14,950 | +6.4% | 0.05% | -27.4% |
| Q1 2022 | $379,000 | -23.9% | 14,050 | +8.5% | 0.07% | -24.0% |
| Q4 2021 | $498,000 | -21.3% | 12,950 | -2.3% | 0.10% | -19.3% |
| Q3 2021 | $633,000 | +82.9% | 13,250 | +7.5% | 0.12% | +60.8% |
| Q2 2021 | $346,000 | +24.5% | 12,325 | +79.3% | 0.07% | +23.3% |
| Q1 2021 | $278,000 | +5.7% | 6,875 | +41.3% | 0.06% | -23.1% |
| Q2 2020 | $263,000 | – | 4,866 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |